Company intelligence / Profile preview

Tellgen

Shanghai, Shanghai, Chinaemis.com ↗

Ownership: Private
Development stage: Commercial

Overview

Tellgen develops state-of-the-art in vitro diagnostic products including tumor marker assays, HPV test kits, ToRCH panels for infectious disease screening, Y chromosome microdeletion tests for male infertility assessment, and multiplex immunoassay systems. The company has an established commercial presence with a broad product portfolio serving clinical laboratories across China.

Modalities: Diagnostic reagents and kits (e.g. Tumor Marker, HPV test kits, ToRCH products)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Tellgen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tellgen.

Explore the full profile